Form 4 for ABBV AbbVie
Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-28 · accession 0001415889-25-006584 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-04 | 2025-02-28 | ABBV | Reents Scott T | EVP, CFO | F - Tax | $205.02 | -11.0K | 29.2K | -27% | -$2.25M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2025-02-28 | F | D | 10,973 | $205.02 | 29,221 | D | — | — |